Search for Clinical Trial Results

Sponsored By

Lymphoma, Large-cell - 16 Studies Found

Status Study
Completed Study Name: Brentuximab Vedotin in Chinese Participants With Relapsed/Refractory CD30-Positive Hodgkin Lymphoma (HL) or Systemic Anaplastic Large Cell Lymphoma (sALCL)
Condition:
  • Hodgkin Disease
  • Lymphoma, Large-Cell, Anaplastic

Date: 2016-10-18
Interventions: Drug: Brentuximab Vedotin Brentuximab vedotin IV infusion.
Completed Study Name: Study of the Biological Mechanisms Associated With the Immunogenicity in Anaplastic Large Cell Lymphoma ( ALCL ) ALK +
Condition: ALCL
Date: 2016-09-07
Interventions: Other: Blood sample
Active, not recruiting Study Name: A Phase 1 Study of Brentuximab Vedotin Given Sequentially and Combined With Multi-Agent Chemotherapy for CD30-Positive Mature T-Cell and NK-Cell Neoplasms
Condition:
  • Lymphoma, Large-Cell, Anaplastic
  • Lymphoma, NK-cell
  • Date: 2011-02-25
    Interventions:
    • Drug: brentuximab vedotin 1.2-
Completed Study Name: Phase II Study of Novantrone(R) (Mitoxantrone) and Etoposide in Patients With HIV Associated Large Cell and Immunoblastic Lymphomas
Condition:
  • Lymphoma, Non-Hodgkin
  • HIV Infections

Date: 1999-11-02
Interventions:
  • Drug: Mitoxantrone hydrochloride
  • Drug: Eto
Completed Study Name: Rituxan vs Bexxar When Combined With Carmustine, Etoposide, Cytarabine and Melphalan (BEAM) With Autologous Hematopoietic Stem Cell Transplantation (BMT CTN 0401)
Condition:
  • Lymphoma, B-Cell
  • Lymphoma, Large-Cell, Immunoblastic
  • Date: 2006-05-22
    Interventions:
    • Drug: Autologous transplantation using rituxan/BEAM

Completed Study Name: Combination Chemotherapy and Rituximab in Treating Patients With HIV-Associated Stage I, Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma
Condition:
  • AIDS-related Diffuse Large Cell Lymphoma
  • AIDS-related Immunoblastic La
    Date: 2002-11-12
    Interventions:
    • Biological: rituximab Given IV
Completed Study Name: Gene Therapy After Frontline Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin Lymphoma
Condition:
  • AIDS-related Non-Hodgkin Lymphoma
  • AIDS-related Plasmablastic Lymphoma<
    Date: 2013-09-09
    Interventions:
    • Drug: busulfan Given IV

Completed Study Name: Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's Lymphoma
Condition: Lymphoma
Date: 1999-11-01
Interventions:
  • Biological: bleomycin sulfate
  • Drug: CHOP r
Not yet recruiting Study Name: Combination Chemotherapy, Rituximab, and Ixazomib Citrate in Treating Patients With Non-Hodgkin Lymphoma
Condition:
  • Adult Burkitt Lymphoma
  • B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between D
    Date: 2015-05-26
    Interventions:
    • Drug: Cyclophosphamide Given I
Active, not recruiting Study Name: Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer
Condition:
  • Accelerated Phase Chronic Myelogenous Leukemia
  • Adult Acute Lymphoblastic Leukemia in Remissi
    Date: 2004-08-04
    Interventions:
    • Drug: fludarabine phosphate Gi
Next >>>